Mingchen Health announced that the company plans to repurchase shares with funds ranging from 30 million to 50 million yuan, with a repurchase price not exceeding 23 yuan per share. The estimated number of shares to be repurchased is approximately 1.3043 million to 2.1739 million shares, accounting for 0.4894% to 0.8156% of the company's total share capital. The repurchased shares will be used for the company's equity incentive plan or employee stock ownership plan. The repurchase period will not exceed 12 months from the date the board of directors approves the repurchase plan. The company's directors, supervisors, senior management, and controlling shareholders have no specific plans for reduction in the next six months and during the repurchase period
